Home › Funds › Venrock Adviser, LLC › ARTV
Venrock Adviser, LLC position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Venrock Adviser, LLC reported holding 2,043,596 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$19.8M, representing 0.60% of its reported portfolio and ranking #24 among its reported holdings. Venrock Adviser, LLC has disclosed ARTV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's ARTV position evolved
Venrock Adviser, LLC first disclosed a stake in ARTV in Q3 2024 at 1,609,569 shares (US$24.9M). Across 8 filings, Venrock Adviser, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,043,596 shares valued at US$19.8M — an increase of 434,027 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.61M | $24.87M | New |
| Q4 2024 | 1.61M | $16.22M | Hold |
| Q1 2025 | 1.61M | $4.83M | Hold |
| Q2 2025 | 1.61M | $2.43M | Hold |
| Q3 2025 | 1.61M | $4.62M | Hold |
| Q4 2025 | 1.61M | $6.91M | Hold |
| Q1 2026 | 1.61M | $10.37M | Hold |
| Q2 2026 | 2.04M | $19.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Caligan Partners LP (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K sh · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K sh · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K sh · $5.09M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M · Q2 2026
- Revelation Capital Management, LLC 299.31K sh · $2.13M · Q3 2026
- KVP Capital Advisors, LP 200.00K sh · $1.94M · Q2 2026
- Velan Capital Investment Management LP 25.00K sh · $242.50K · Q2 2026
- Spark Investment Management LLC 16.50K sh · $160.05K · Q2 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held ARTV?
Venrock Adviser, LLC has disclosed ARTV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Venrock Adviser, LLC's current position in ARTV?
As of Q2 2026, Venrock Adviser, LLC holds 2.04M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $19.82M, representing 0.60% of its reported portfolio and ranking #24.
Has Venrock Adviser, LLC been buying or selling ARTV?
In the latest 13F filing (Q2 2026), Venrock Adviser, LLC increased its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Caligan Partners LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.